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Results: 
 
In figure 1 the reconstructed and literature σ values of 
muscle, bladder and cervical tumor tissue are presented. 
Results show σ values of muscle tissue which are 15-30% 
elevated compared to literature values. Moreover, the 
reconstructed σ values of the bladder were up to 10 times 
higher than values currently used in HTP. Furthermore, for 
75% of the squamous cell carcinomas the σ values were 5-12% 
higher than the σ of muscle tissue. The reconstructed σ of 
the adenocarcinoma was 22% higher compared to muscle 
tissue. 
Conclusions: This study demonstrated the feasibility to 
quantitatively measure the σ of healthy tissue and tumors in 
vivo. The measured conductivities were higher than those 
reported in literature, which could probably be explained by 
the higher blood and water content during living conditions. 
A decrease of σ after death has been reported in literature in 
studies with (human) liver, (animal) brain and (animal) 
muscle tissue. The present study showed that the commonly 
unknown tumor σ is 5-12% higher compared to the in vivo σ of 
muscle. The reconstructed bladder σ was much higher than 
the value currently used in HTP. This can be explained by the 
fact that the σ value reported in the literature corresponds 
to the bladder tissue, not accounting for the highly 
conductive urine. Future studies will determine to which 
extent the reliability of HTP improves when using these 
patient-specific σ values.  
   
OC-0066   
Prostate cancer radiation therapy response assessed with 
MRI and [11C]Acetate PET in the absence of a hybrid 
scanner 
P. Andrzejewski1,4, P. Balzer2,4, J. Knoth1,4, P. Kuess1,4, S. 
Polanec2,4, G. Goldner1,4, W. Wadsak2,4, D. Georg1,4, T.H. 
Helbich2,4, P. Georg3,4 
1Medical University Vienna, Department of Radion Oncology, 
Vienna, Austria  
2Medical University Vienna, Biomedical Imaging and Image-
guided Therapy, Vienna, Austria  
3EBG MedAustron GmbH, Vienna, Austria  
4Christian Doppler Laboratory for Medical Radiation Research 
for Radiation Oncology, Vienna, Austria  
 
Purpose/Objective: To evaluate the feasibility of prostate 
cancer EBRT response assessment with [11C]Acetate PET and 
multiparametric magnetic resonance imaging (mpMRI) in the 
absence of a hybrid MR-PET scanner. The study aimed at 
finding the correlation of quantitative parameters changes 
derived from different imaging modalities during the course 
of treatment. 
Materials and Methods: Four cases with biopsy-confirmed 
prostate cancer were included in this IRB approved study. 
Patients received a prescribed dose of 78Gy to the prostate 
and 50.4Gy to elective pelvic nodes. PET-CT and mpMRI scans 
were performed at 4 time points: before RT, after 2 and 4 
weeks of treatment (at ~20 and 40 Gy) and at 3 months after 
RT. For the PET exam 740MBq of [11C]Acetate were injected 
and patients were imaged 20 minutes later. 3T mpMRI scan 
consisted of the following sequences: T2-weighted turbo spin 
echo, diffusion-weighted single-shot echo-planar imaging 
(DWI), 3D Chemical Shift Imaging spectroscopy (CSI) and 
dynamic contrast enhanced (DCE) T1-weighted gradient echo 
with 70 repetitions. ADC, Ktrans, iAUC and Cho+Cr/Ci-ratio 
maps were generated using the Syngo® (Siemens, Germany). 
All images were registered and analzyed in the Mirada RTx 
(Mirada Medical Ltd, UK) using automatic and manual rigid 
registration with respect to three reference gold markers. 
Series of structures (defined on datasets from all consecutive 
time points) consisted of: focal lesion visible on particular 
modality (T2w; ADC-, Ktrans-, iAUC-maps and PET), reference 
PET structure (Gluteus maximus m.) to calculate TBR and the 
dominant intraprostatic lesion (DIL) based on all imaging 
modalities. DIL defined at the baseline was also copied to 
remaining time points (DILB2-4) to assess temporal stability of 
the DIL. Variations in quantitative parameters were extracted 
from the respective imaging series. Statistical analyses were 
performed on collected data. 
Results: Manually delineated DIL mean volume at the 
baseline was 3.1±1.6cc and decreased to 0.25±0.25cc at 
follow up (with 23.0±3.8% and 44.3±28.5% decrease after 2 
and 4 weeks, respectively). Means of quantitative parameters 
in the DIL volumes between baseline and follow up changed 
as follows: ADC increased by 27.1±7.4%, Ktrans decreased by 
41.5±11.4% and iAUC by 34.8±12.2%. Intensity on T2w images 
decreased by 5.2±7.9% and TBR dropped by 25.1±6.5%. The 
behavior of these parameters during treatment differed 
between cases. For example for one patient the lesion was 
not visible on T2w images already after 20Gy, whereas for 
another one it could be recognized even in follow up after 
78Gy. 
Conclusions: Prostate cancer RT assessment is feasible with 
combined [11C]Acetate PET and mpMRI performed on separate 
scanners. Special care has to be devoted to the process of 
image registration. Data derived from different modalities 
complement each other but their correlations need further 
investigations. There is clear inter-patient response variation 
but more patients and long term follow up is needed. The 
impact of temporal DIL variations on boost strategies needs 
further investigation.  
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Purpose/Objective: Neoadjuvant chemoradiotherapy (nCRT) 
is often used for the treatment of resectable esophageal 
cancer. In 29% of the patients complete pathologic response 
(pCr) has been found. When accurate prediction of treatment 
response is available, surgery may potentially be omitted in 
case of pCr. Changes in tumor microvasculature are reflected 
in dynamic contrast enhanced (DCE) MRI, which is therefore 
